The global Molecular Imaging Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Modality (Molecular Ultrasound Imaging, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Nuclear Magnetic Resonance (NMR) Spectrometer, Others), By Application (Cardiovascular, Neurology, Oncology, Respiratory, Gastrointestinal), By End-User (Hospitals, Diagnostic Imaging Centers, Research Institutes).
The molecular imaging market is experiencing robust growth in 2025, fueled by advancements in diagnostic technologies and the increasing focus on personalized medicine. Molecular imaging techniques, such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and MRI (Magnetic Resonance Imaging), allow for the non-invasive visualization of molecular processes within the body, providing essential insights into diseases at an early stage. These techniques are becoming increasingly important in the diagnosis and monitoring of cancer, cardiovascular diseases, and neurological disorders. The market is further driven by the development of targeted molecular probes, which enhance the precision of imaging techniques, making them crucial for personalized treatment plans. The rise of artificial intelligence and machine learning in molecular imaging is improving image interpretation and diagnostic accuracy, which is propelling the growth of this market. North America, followed by Europe and Asia-Pacific, is expected to dominate the market due to the high adoption of advanced healthcare technologies and the presence of key market players.
The market report analyses the leading companies in the industry including Bruker, Canon Medical Systems Corp, Cubresa Inc, GE HealthCare, Koninklijke Philips N.V., Mediso Ltd, Positron, Shimadzu Corp, Siemens Healthineers AG, United Imaging Healthcare Co. Ltd, and others.
The molecular imaging market is witnessing a shift towards hybrid imaging technologies, combining multiple imaging modalities like PET, CT, MRI, and SPECT. These hybrid systems enable a more comprehensive view of molecular processes in vivo, enhancing the accuracy of diagnosis and treatment monitoring. The convergence of technologies allows for better resolution, faster imaging, and a more precise diagnosis of diseases like cancer, neurological disorders, and cardiovascular conditions. This trend is particularly driven by advancements in molecular probes and contrast agents that enhance the specificity of imaging for targeted therapies.
The growing emphasis on early diagnosis and personalized treatment plans is a major driver for the molecular imaging market. As precision medicine continues to evolve, there is a rising need for advanced imaging techniques that can detect diseases at the molecular and cellular levels. Molecular imaging technologies, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), play a critical role in detecting tumors, assessing metabolic activity, and monitoring disease progression, making them invaluable in oncology, cardiology, and neurology.
An exciting opportunity lies in the integration of artificial intelligence (AI) and machine learning (ML) algorithms into molecular imaging systems. These technologies can help automate image analysis, improving the speed and accuracy of diagnoses while reducing human error. AI-driven image interpretation and predictive analytics could significantly enhance the clinical value of molecular imaging, making it more accessible and cost-effective. Furthermore, AI-enabled tools could assist in identifying patterns that are not visible to the human eye, unlocking new insights into disease mechanisms and treatment efficacy.
The Positron Emission Tomography (PET) segment is projected to lead the molecular imaging market by 2025, owing to its pivotal role in both clinical and research applications, particularly in oncology, cardiology, and neurology. PET imaging offers high sensitivity and the ability to visualize metabolic processes within the body, making it an indispensable tool for detecting and diagnosing various diseases at early stages. The increasing demand for non-invasive diagnostic techniques and personalized medicine is further driving the growth of the PET segment. Moreover, advancements in PET scanner technology and the rising prevalence of chronic diseases, such as cancer and cardiovascular conditions, are expected to propel PET's dominance in the molecular imaging market, providing more precise diagnostic and therapeutic insights.
The oncology segment is expected to experience the fastest growth in the molecular imaging market through 2034, driven by the increasing demand for advanced diagnostic tools and personalized treatments in cancer care. Molecular imaging techniques, which provide detailed, real-time images of molecular and cellular processes within the body, are revolutionizing cancer diagnosis, staging, and treatment monitoring. As the prevalence of cancer continues to rise globally, the need for precise and non-invasive imaging technologies becomes even more critical. Molecular imaging, particularly with the use of PET scans, CT scans, and MRI, is instrumental in detecting early-stage cancers and monitoring the efficacy of treatments. This growing reliance on advanced imaging solutions, alongside continuous innovations in radiotracers and imaging modalities, will lead to the oncology segment becoming the fastest-growing area of the molecular imaging market.
The molecular imaging market in China is experiencing significant growth due to advancements in healthcare infrastructure, rising healthcare expenditure, and the increasing adoption of cutting-edge technologies in diagnostics. As one of the world’s largest healthcare markets, China is witnessing increased demand for molecular imaging techniques such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) for early diagnosis of diseases like cancer, cardiovascular conditions, and neurological disorders. The Chinese government's support for research and development in the medical imaging sector, along with investments in healthcare facilities, is accelerating the adoption of molecular imaging technologies. Additionally, the growing geriatric population and rising prevalence of chronic diseases are contributing to the expansion of the market in China.
India’s molecular imaging market is set for rapid growth as the country modernizes its healthcare infrastructure and adopts advanced diagnostic technologies. The increasing burden of diseases such as cancer, neurological disorders, and cardiovascular diseases has led to a growing demand for non-invasive diagnostic methods like PET, MRI, and SPECT imaging. Moreover, the rising awareness of early disease detection and the increasing focus on preventive healthcare are key drivers for molecular imaging adoption. India’s burgeoning healthcare sector, along with rising investments from both public and private sectors, is expected to accelerate the use of molecular imaging technologies across hospitals and diagnostic centers. Additionally, the country’s expanding medical tourism industry is creating a significant opportunity for the market.
The United States remains a global leader in the molecular imaging market, driven by technological innovations, a strong healthcare system, and increasing demand for precise, early-stage disease detection. With the rapid adoption of technologies such as PET, SPECT, and molecular MRI, the U.S. market continues to grow as these imaging techniques are crucial for accurate diagnosis and treatment monitoring in oncology, cardiology, and neurology. The rising incidence of cancer, heart disease, and neurodegenerative disorders is pushing the demand for advanced diagnostic tools. Additionally, the increasing adoption of personalized medicine, which relies on molecular imaging for tailored treatment, is expected to further fuel market growth. Research and development in the molecular imaging sector, along with the presence of key market players and technological advancements, position the U.S. as a dominant force in the market.
Germany’s molecular imaging market is poised for growth, driven by its well-established healthcare infrastructure and ongoing innovations in medical technology. The country’s healthcare system, known for its high standards, is increasingly adopting molecular imaging techniques for non-invasive diagnostics in areas such as oncology, cardiology, and neurology. The German government’s focus on improving healthcare accessibility and the rapid adoption of advanced imaging technologies are key drivers of the market. Moreover, Germany’s emphasis on research and development in the life sciences sector is fostering innovation in molecular imaging modalities, further boosting market growth. The increasing number of diagnostic imaging centers and hospitals investing in cutting-edge technologies is also contributing to the expansion of this market in Germany.
In France, the molecular imaging market is seeing strong growth due to increasing demand for advanced diagnostic tools and a rising focus on personalized medicine. The country’s well-established healthcare system and high level of research investment in medical technologies are pivotal in supporting the adoption of molecular imaging techniques like PET, SPECT, and MRI. With a high prevalence of chronic diseases such as cancer and cardiovascular disorders, there is a growing need for precise and early diagnosis to improve treatment outcomes. France’s government-backed initiatives and funding for medical imaging technologies, alongside the country’s focus on cutting-edge healthcare solutions, are accelerating the adoption of molecular imaging in hospitals and diagnostic centers.
The molecular imaging market in the Middle East is experiencing significant growth due to the region’s increasing investments in healthcare infrastructure and technology. Countries like the UAE, Saudi Arabia, and Qatar are expanding their healthcare systems, introducing advanced diagnostic technologies to enhance the accuracy of disease detection. The rising incidence of chronic diseases, particularly cancer and cardiovascular disorders, is driving the demand for molecular imaging techniques such as PET and SPECT. Additionally, the region’s focus on attracting medical tourism and the growing adoption of personalized medicine are contributing to the demand for non-invasive imaging methods. The Middle East’s commitment to improving healthcare standards and integrating advanced technologies is poised to fuel the growth of the molecular imaging market in the coming years.
|
Parameter |
Details |
|
Market Size (2025) |
$9.2 Billion |
|
Market Size (2034) |
$13.7 Billion |
|
Market Growth Rate |
4.5% |
|
Segments |
By Modality (Molecular Ultrasound Imaging, Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Nuclear Magnetic Resonance (NMR) Spectrometer, Others), By Application (Cardiovascular, Neurology, Oncology, Respiratory, Gastrointestinal), By End-User (Hospitals, Diagnostic Imaging Centers, Research Institutes) |
|
Study Period |
2019- 2024 and 2025-2034 |
|
Units |
Revenue (USD) |
|
Qualitative Analysis |
Porter’s Five Forces, SWOT Profile, Market Share, Scenario Forecasts, Market Ecosystem, Company Ranking, Market Dynamics, Industry Benchmarking |
|
Companies |
Bruker, Canon Medical Systems Corp, Cubresa Inc, GE HealthCare, Koninklijke Philips N.V., Mediso Ltd, Positron, Shimadzu Corp, Siemens Healthineers AG, United Imaging Healthcare Co. Ltd |
|
Countries |
US, Canada, Mexico, Germany, France, Spain, Italy, UK, Russia, China, India, Japan, South Korea, Australia, South East Asia, Brazil, Argentina, Middle East, Africa |
By Modality
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Others
By Application
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
By End-User
Hospitals
Diagnostic Imaging Centers
Research Institutes
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Bruker
Canon Medical Systems Corp
Cubresa Inc
GE HealthCare
Koninklijke Philips N.V.
Mediso Ltd
Positron
Shimadzu Corp
Siemens Healthineers AG
United Imaging Healthcare Co. Ltd
*- List Not Exhaustive
About USD Analytics
Table of Contents
List of Charts and Exhibits
List of Tables
1. Executive Summary
What’s New in 2025?
Top 10 Takeaways from the industry
Potential Opportunities for Industry Stakeholders
Strategic Imperatives
Company Market Positioning
Industry Benchmarking Matrix
2. Research Scope and Methodology
Market Definition
- Market Segments
- Companies Profiled
Research Methodology
- Bottom-Up Method
- Top-Down Method
- Data Triangulation
Forecast Methodology
- Data Sources
- USDA Proprietary Databases
- External Sources
- Primary Research and Interviews
Conversion Rates for USD
Abbreviations
3. Strategic Landscape: Key Insights and Implications
Spotlight: Key Strategies opted by Business Leaders
Competitive Landscape
Market Size ($ Million) and Share (%) by Company, 2024
SWOT Analysis
- Key Market Strengths
- Key Market Weaknesses
- Potential Opportunities
- Potential Threats
Porter’s Five Force Analysis
- Summary
- Bargaining Power of Buyers- Impact Analysis
- Bargaining Power of Suppliers- Impact Analysis
- Threat of new entrants- Impact Analysis
- Intensity of Competitive Rivalry- Impact Analysis
Macro-Environmental Analysis
- Economic forecasts by Country, 2010- 2035
- Population forecasts by Country, 2010- 2035
- Inflation Outlook by Country, 2010-2035
- Impact of Russia-Ukraine Conflict, Sluggish China Growth, US Developments
5. Growth Opportunity Analysis
Trends at a Glance
- What are the most noteworthy trends in the market
- Where should leaders pay attention?
- What industries are likely to be affected by the growth?
Market Dynamics
- Charting a path forward
- Growth Drivers
- Growth Barriers
Key Industry Stakeholders
- Suppliers
- Manufacturers and Service Providers
- Distribution Channels
- End-Users and Applications
- Regulators
- Investors, Traders, and R&D Institutes
Regulatory Landscape
6. Market Size Outlook to 2034
Global Molecular Imaging Market Size Forecast, USD Million, 2018- 2034
- Historic Market Size, 2018- 2024
- Forecast Market Size, 2024- 2034
Scenario Analysis
- Low Growth Scenario: Definition and Outlook to 2034
- Reference Case: Definition and Outlook to 2034
- High Growth Scenario: Definition and Outlook to 2034
Pricing Analysis and Outlook
- Molecular Imaging Average Price Forecast, 2021- 2034
- Key Factors Shaping the Pricing Patterns
7. Historical Molecular Imaging Market Size by Segments, 2018- 2024
Key Statistics, 2024
Molecular Imaging Market Size Outlook by Type, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Molecular Imaging Types, 2018- 2024
Molecular Imaging Market Size Outlook by Application, USD Million, 2018- 2024
Growth Comparison (y-o-y) across Molecular Imaging Applications, 2018- 2024
8. Molecular Imaging Market Size Outlook by Segments, 2024- 2034
By Modality
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Others
By Application
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
By End-User
Hospitals
Diagnostic Imaging Centers
Research Institutes
9. Molecular Imaging Market Size Outlook by Region
North America
Key Market Dynamics
North America Molecular Imaging Market Size Outlook by Type, USD Million, 2021-2034
North America Molecular Imaging Market Size Outlook by Application, USD Million, 2021-2034
North America Molecular Imaging Market Size Outlook by Sales Channel, USD Million, 2021-2034
North America Molecular Imaging Market Size Outlook by Country, USD Million, 2021-2034
Europe
Key Market Dynamics
Europe Molecular Imaging Market Size Outlook by Type, USD Million, 2021-2034
Europe Molecular Imaging Market Size Outlook by Application, USD Million, 2021-2034
Europe Molecular Imaging Market Size Outlook by Sales Channel, USD Million, 2021-2034
Europe Molecular Imaging Market Size Outlook by Country, USD Million, 2021-2034
Asia Pacific
Key Market Dynamics
Asia Pacific Molecular Imaging Market Size Outlook by Type, USD Million, 2021-2034
Asia Pacific Molecular Imaging Market Size Outlook by Application, USD Million, 2021-2034
Asia Pacific Molecular Imaging Market Size Outlook by Sales Channel, USD Million, 2021-2034
Asia Pacific Molecular Imaging Market Size Outlook by Country, USD Million, 2021-2034
South America
Key Market Dynamics
South America Molecular Imaging Market Size Outlook by Type, USD Million, 2021-2034
South America Molecular Imaging Market Size Outlook by Application, USD Million, 2021-2034
South America Molecular Imaging Market Size Outlook by Sales Channel, USD Million, 2021-2034
South America Molecular Imaging Market Size Outlook by Country, USD Million, 2021-2034
Middle East and Africa
Key Market Dynamics
Middle East and Africa Molecular Imaging Market Size Outlook by Type, USD Million, 2021-2034
Middle East and Africa Molecular Imaging Market Size Outlook by Application, USD Million, 2021-2034
Middle East and Africa Molecular Imaging Market Size Outlook by Sales Channel, USD Million, 2021-2034
Middle East and Africa Molecular Imaging Market Size Outlook by Country, USD Million, 2021-2034
10. United States Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
United States Molecular Imaging Market Size Outlook by Type, 2021- 2034
United States Molecular Imaging Market Size Outlook by Application, 2021- 2034
United States Molecular Imaging Market Size Outlook by End-User, 2021- 2034
11. Canada Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Canada Molecular Imaging Market Size Outlook by Type, 2021- 2034
Canada Molecular Imaging Market Size Outlook by Application, 2021- 2034
Canada Molecular Imaging Market Size Outlook by End-User, 2021- 2034
12. Mexico Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Mexico Molecular Imaging Market Size Outlook by Type, 2021- 2034
Mexico Molecular Imaging Market Size Outlook by Application, 2021- 2034
Mexico Molecular Imaging Market Size Outlook by End-User, 2021- 2034
13. Germany Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Germany Molecular Imaging Market Size Outlook by Type, 2021- 2034
Germany Molecular Imaging Market Size Outlook by Application, 2021- 2034
Germany Molecular Imaging Market Size Outlook by End-User, 2021- 2034
14. France Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
France Molecular Imaging Market Size Outlook by Type, 2021- 2034
France Molecular Imaging Market Size Outlook by Application, 2021- 2034
France Molecular Imaging Market Size Outlook by End-User, 2021- 2034
15. United Kingdom Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
United Kingdom Molecular Imaging Market Size Outlook by Type, 2021- 2034
United Kingdom Molecular Imaging Market Size Outlook by Application, 2021- 2034
United Kingdom Molecular Imaging Market Size Outlook by End-User, 2021- 2034
16. Spain Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Spain Molecular Imaging Market Size Outlook by Type, 2021- 2034
Spain Molecular Imaging Market Size Outlook by Application, 2021- 2034
Spain Molecular Imaging Market Size Outlook by End-User, 2021- 2034
17. Italy Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Italy Molecular Imaging Market Size Outlook by Type, 2021- 2034
Italy Molecular Imaging Market Size Outlook by Application, 2021- 2034
Italy Molecular Imaging Market Size Outlook by End-User, 2021- 2034
18. Benelux Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Benelux Molecular Imaging Market Size Outlook by Type, 2021- 2034
Benelux Molecular Imaging Market Size Outlook by Application, 2021- 2034
Benelux Molecular Imaging Market Size Outlook by End-User, 2021- 2034
19. Nordic Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Nordic Molecular Imaging Market Size Outlook by Type, 2021- 2034
Nordic Molecular Imaging Market Size Outlook by Application, 2021- 2034
Nordic Molecular Imaging Market Size Outlook by End-User, 2021- 2034
20. Rest of Europe Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Europe Molecular Imaging Market Size Outlook by Type, 2021- 2034
Rest of Europe Molecular Imaging Market Size Outlook by Application, 2021- 2034
Rest of Europe Molecular Imaging Market Size Outlook by End-User, 2021- 2034
21. China Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
China Molecular Imaging Market Size Outlook by Type, 2021- 2034
China Molecular Imaging Market Size Outlook by Application, 2021- 2034
China Molecular Imaging Market Size Outlook by End-User, 2021- 2034
22. India Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
India Molecular Imaging Market Size Outlook by Type, 2021- 2034
India Molecular Imaging Market Size Outlook by Application, 2021- 2034
India Molecular Imaging Market Size Outlook by End-User, 2021- 2034
23. Japan Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Japan Molecular Imaging Market Size Outlook by Type, 2021- 2034
Japan Molecular Imaging Market Size Outlook by Application, 2021- 2034
Japan Molecular Imaging Market Size Outlook by End-User, 2021- 2034
24. South Korea Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
South Korea Molecular Imaging Market Size Outlook by Type, 2021- 2034
South Korea Molecular Imaging Market Size Outlook by Application, 2021- 2034
South Korea Molecular Imaging Market Size Outlook by End-User, 2021- 2034
25. Australia Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Australia Molecular Imaging Market Size Outlook by Type, 2021- 2034
Australia Molecular Imaging Market Size Outlook by Application, 2021- 2034
Australia Molecular Imaging Market Size Outlook by End-User, 2021- 2034
26. South East Asia Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
South East Asia Molecular Imaging Market Size Outlook by Type, 2021- 2034
South East Asia Molecular Imaging Market Size Outlook by Application, 2021- 2034
South East Asia Molecular Imaging Market Size Outlook by End-User, 2021- 2034
27. Rest of Asia Pacific Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Asia Pacific Molecular Imaging Market Size Outlook by Type, 2021- 2034
Rest of Asia Pacific Molecular Imaging Market Size Outlook by Application, 2021- 2034
Rest of Asia Pacific Molecular Imaging Market Size Outlook by End-User, 2021- 2034
28. Brazil Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Brazil Molecular Imaging Market Size Outlook by Type, 2021- 2034
Brazil Molecular Imaging Market Size Outlook by Application, 2021- 2034
Brazil Molecular Imaging Market Size Outlook by End-User, 2021- 2034
29. Argentina Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Argentina Molecular Imaging Market Size Outlook by Type, 2021- 2034
Argentina Molecular Imaging Market Size Outlook by Application, 2021- 2034
Argentina Molecular Imaging Market Size Outlook by End-User, 2021- 2034
30. Rest of South America Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of South America Molecular Imaging Market Size Outlook by Type, 2021- 2034
Rest of South America Molecular Imaging Market Size Outlook by Application, 2021- 2034
Rest of South America Molecular Imaging Market Size Outlook by End-User, 2021- 2034
31. United Arab Emirates Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
United Arab Emirates Molecular Imaging Market Size Outlook by Type, 2021- 2034
United Arab Emirates Molecular Imaging Market Size Outlook by Application, 2021- 2034
United Arab Emirates Molecular Imaging Market Size Outlook by End-User, 2021- 2034
32. Saudi Arabia Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Saudi Arabia Molecular Imaging Market Size Outlook by Type, 2021- 2034
Saudi Arabia Molecular Imaging Market Size Outlook by Application, 2021- 2034
Saudi Arabia Molecular Imaging Market Size Outlook by End-User, 2021- 2034
33. Rest of Middle East Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Middle East Molecular Imaging Market Size Outlook by Type, 2021- 2034
Rest of Middle East Molecular Imaging Market Size Outlook by Application, 2021- 2034
Rest of Middle East Molecular Imaging Market Size Outlook by End-User, 2021- 2034
34. South Africa Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
South Africa Molecular Imaging Market Size Outlook by Type, 2021- 2034
South Africa Molecular Imaging Market Size Outlook by Application, 2021- 2034
South Africa Molecular Imaging Market Size Outlook by End-User, 2021- 2034
35. Rest of Africa Molecular Imaging Market Analysis and Outlook, 2021- 2034
Key Statistics
Rest of Africa Molecular Imaging Market Size Outlook by Type, 2021- 2034
Rest of Africa Molecular Imaging Market Size Outlook by Application, 2021- 2034
Rest of Africa Molecular Imaging Market Size Outlook by End-User, 2021- 2034
36. Key Companies
Market Share Analysis
Bruker
Canon Medical Systems Corp
Cubresa Inc
GE HealthCare
Koninklijke Philips N.V.
Mediso Ltd
Positron
Shimadzu Corp
Siemens Healthineers AG
United Imaging Healthcare Co. Ltd
Company Benchmarking
Financial Analysis
37. Recent Market Developments
38. Appendix
Looking Ahead
Research Methodology
Legal Disclaimer
By Modality
Molecular Ultrasound Imaging
Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Nuclear Magnetic Resonance (NMR) Spectrometer
Others
By Application
Cardiovascular
Neurology
Oncology
Respiratory
Gastrointestinal
By End-User
Hospitals
Diagnostic Imaging Centers
Research Institutes
The Global Molecular Imaging Market Size is estimated at $9.2 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 4.5% to reach $13.7 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Bruker, Canon Medical Systems Corp, Cubresa Inc, GE HealthCare, Koninklijke Philips N.V., Mediso Ltd, Positron, Shimadzu Corp, Siemens Healthineers AG, United Imaging Healthcare Co. Ltd
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume